RGS-Rz and RGS9-2 proteins control mu-opioid receptor desensitisation in CNS: the role of activated Gαz subunits-Reference-Cited by-同舟云学术

RGS-Rz and RGS9-2 proteins control mu-opioid receptor desensitisation in CNS: the role of activated Gαz subunits

Published:2005-01 Issue:1 Volume:48 Page:134-150
ISSN:0028-3908
Container-title:Neuropharmacology
language:en
Short-container-title:Neuropharmacology

Author:

Sánchez-Blázquez Pilar,Rodríguez-Muñoz María,Montero Carlos,Garzón Javier

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience,Pharmacology

Reference48 articles.

1. Selective blockage of delta opioid receptors prevents the development of morphine tolerance and dependence in mice;Abdelhamid;Journal of Pharmacology and Experimental Therapeutics,1991

2. Mu and delta opioid receptors activate the same G proteins in human neuroblastome SH-SY5Y cells;Alt;British Journal of Pharmacology,2002

3. Evidence for transduction of mu but not kappa opioid modulation of extracellular signal-regulated kinase activity by Gz and G12 proteins;Belcheva;Cell Signalling,2000

4. Abused drugs modulate RGS4 mRNA levels in rat brain: comparison between acute drug treatment and a drug challenge after chronic treatment;Bishop;Neurobiology of Disease,2002

5. Gz, a guanine nucleotide-binding protein with unique biochemical properties;Casey;Journal of Biological Chemistry,1990

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regulator of G Protein Signaling 17 as a Negative Modulator of GPCR Signaling in Multiple Human Cancers;The AAPS Journal;2016-02-29

2. RGS proteins as targets in the treatment of intestinal inflammation and visceral pain: New insights and future perspectives;BioEssays;2016-01-28

3. Regulators of G-Protein-Signaling Proteins: Negative Modulators of G-Protein-Coupled Receptor Signaling;International Review of Cell and Molecular Biology;2015

4. Nitric Oxide and Zinc-Mediated Protein Assemblies Involved in Mu Opioid Receptor Signaling;Molecular Neurobiology;2013-05-11

5. Evidence from basic research for opioid combinations;Expert Opinion on Drug Discovery;2012-01-04